Your browser doesn't support javascript.
loading
CRISPR-prime editing, a versatile genetic tool to create specific mutations with a single nucleotide resolution in Leptospira.
Fernandes, Luis Guilherme Virgilio; Hamond, Camila; Tibbs-Cortes, Bienvenido W; Putz, Ellie J; Olsen, Steven C; Palmer, Mitchell V; Nally, Jarlath E.
Afiliação
  • Fernandes LGV; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
  • Hamond C; National Veterinary Services Laboratories, USDA Animal and Plant Health Inspection Service, National Center for Animal Health, Ames, Iowa, USA.
  • Tibbs-Cortes BW; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
  • Putz EJ; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
  • Olsen SC; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
  • Palmer MV; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
  • Nally JE; Infectious Bacterial Disease Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA.
mBio ; : e0151624, 2024 Aug 13.
Article em En | MEDLINE | ID: mdl-39136471
ABSTRACT
Leptospirosis, caused by pathogenic bacteria from the genus Leptospira, is a global zoonosis responsible for more than one million human cases and 60,000 deaths annually. The disease also affects many domestic animal species. Historically, genetic manipulation of Leptospira has been difficult to perform, resulting in limited knowledge on pathogenic mechanisms of disease and the identification of virulence factors. The application of CRISPR/Cas9 and its variations have helped fill these gaps but the generation of knockout mutants remains challenging because double-strand breaks (DSBs) inflicted by Cas9 nuclease are lethal to Leptospira cells. The novel CRISPR prime editing (PE) strategy is the first precise genome-editing technology that allows deletions, insertions, and base substitutions without introducing DSBs. This revolutionary technique utilizes a nickase Cas9 that cleaves a single strand of DNA, coupled with an engineered reverse transcriptase and a modified single-guide RNA (termed prime editing guide RNA) containing an extended 3' end with the desired edits. We demonstrate the application of CRISPR-PE in both saprophytic and pathogenic Leptospira from multiple species and serovars by introducing deletions or insertions into target DNA with a remarkable precision of just one nucleotide. Additionally, we demonstrate the ability to genetically manipulate Leptospira borgpetersenii, a prevalent pathogenic species of humans, domestic cattle, and wildlife animals. Rapid plasmid loss by mutated strains in liquid culture allows for the generation of knockout strains without selective markers, which can be readily used to elucidate virulence factors and develop optimized bacterin and/or live vaccines against leptospirosis.IMPORTANCELeptospirosis is a geographically widespread bacterial zoonosis. Genetic manipulation of pathogenic Leptospira spp. has been laborious and difficult to perform, limiting our ability to understand how leptospires cause disease. The application of the CRISPR/Cas9 system to Leptospira enhanced our ability to generate knockdown and knockout mutants; however, the latter remains challenging. Here, we demonstrate the application of the CRISPR prime editing technique in Leptospira, allowing the generation of knockout mutants in several pathogenic species, with mutations comprising just a single nucleotide resolution. Notably, we generated a mutant in the Leptospira borgpetersenii background, a prevalent pathogenic species of humans and cattle. Our application of this method opens new avenues for studying pathogenic mechanisms of Leptospira and the identification of virulence factors across multiple species. These methods can also be used to facilitate the generation of marker-less knockout strains for updated and improved bacterin and/or live vaccines.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article